Federated Hermes’s Checkpoint Therapeutics CKPT Stock Holding History

Federated Hermes’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-117	Closed	-$4K	–	2214
2019 Q2	$4K	Buy	+117	New	+$4.59K	﹤0.01%	2009

Other funds holding CKPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Federated Hermes's CKPT Position: Q3 2019 in Review

Federated Hermes sold out of Checkpoint Therapeutics (CKPT) in Q3 2019, closing a stake of 117 shares — an estimated $4K sold.

Federated Hermes first reported a position in CKPT in Q2 2019 and held it in 1 quarter. The position peaked at $4K in Q2 2019. 37 funds tracked by Wall St. Rank hold CKPT as of Q3 2019.

Federated Hermes reported no remaining Checkpoint Therapeutics position as of Q3 2019 after selling out during the quarter.
Federated Hermes sold 117 Checkpoint Therapeutics shares in Q3 2019, an estimated $4K.
Federated Hermes first reported a position in Checkpoint Therapeutics in Q2 2019 and held it in 1 quarter.
Federated Hermes's Checkpoint Therapeutics position peaked at $4K in Q2 2019.
37 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2019.

Based on Federated Hermes's 13F filing for Q3 2019, filed 14 Nov 2019.